Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi Research Article
Costs Effectiveness of Domestic Violence Screening in Primary Care Settings: A Comparison of 3 Methods
Ping-Hsin Chen1* Sue R Rovi* Mark S Johnson2
1Assistant Professor, Department of Family Medicine, Rutgers University-New Jersey Medical School, USA
2Dean, Howard University College of Medicine, USA
- *Corresponding Author:
- Ping-Hsin Chen
Assistant Professor
Department of Family Medicine
Rutgers University-New Jersey Medical School
Newark, NJ.183 S. Orange Avenue
Newark, NJ 07103, USA
Tel: (973) 972-7979
E-mail: chenpi@njms.rutgers.edu
Received date: October 16, 2013; Accepted date: November 20, 2013; Published date: November 22, 2013
Citation: Chen PH, Rovi SR, Pan KY, Johnson MS (2013) Costs Effectiveness of Domestic Violence Screening in Primary Care Settings: A Comparison of 3 Methods. J Community Med Health Educ 3:253. doi: 10.4172/2161-0711.1000253
Copyright: © 2013 Chen PH, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Abstract
Purpose: To compare the cost effectiveness of brief domestic violence (DV) screening tools used in three screening protocols: self-administered, medical staff interview, and physician interview. Methods: We conducted secondary analyses of data collected at 4 urban primary care settings during July 2004 through June 2005. The primary study was a randomized trial of 523 female patients who were assigned to 1 of the 3 screening protocols. Inclusion criteria were women aged 18 or older and currently involved with a partner. Each screening protocol included two brief DV screening tools, HITS and WAST-Short. Patients completed a post-screening survey to assess time spent screening. Data on provider salaries and training costs were also collected. Outcome measures were the costs to have one DV disclosure for each screening protocol. Sensitivity analyses were conducted to assess the robustness of the cost analysis. Results: With an overall disclosure rate of 14%, no difference was found among the three protocols. Costs for one DV disclosure by screening protocol were $9.98 for the self-administered, $15.46 for the medical staff interview, and $62.03 for the physician interview. For each protocol, increases in disclosure rates, proportion of patients screened, or screening frequency might reduce the average costs of screening. Conclusions: Patient self-administered disclosure of DV is less costly compared with provider interview. In terms of costs, this study supports routine or universal DV screening in primary care settings.
